NCT04748328

Brief Summary

The study was a prospective observational analysis of cases with complete ACL tears. A study was conducted between February 2021 to December 2024. All the patients attending those hospitals' emergency or outpatient departments (OPD) with knee injuries were evaluated for an ACL tear. Patients who meet inclusion criteria and consent to participate in the study will be observed for two years. Patients in Arifin Achmad Hospital Pekanbaru will follow rehabilitation treatment and optional delayed reconstruction after 12 weeks if needed, while patients in some hospitals in Jakarta and Bandung (Cipto Mangunkusumo Hospital, Gatot Subroto Army Hospital, Hasan Sadikin Hospital) will perform early reconstruction treatment. After receiving informed consent, all subjects received a self-administered patient questionnaire containing the International Knee Documentation Committee (IKDC) score, EQ5D3L, and Tegner Activity Level (TAL) scores. These questionnaires will be measured at 0, 12, 24, 48, and 96 weeks. Clinical value of the Lachman test and pivot shift test will be performed. One independent orthopedic surgeon will keep all records and evaluate the results. All costs for the treatment will be accounted for.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 10, 2021

Completed
19 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

3.3 years

First QC Date

January 26, 2021

Last Update Submit

May 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of Questionnaire of International Knee Documentation Committee (IKDC Questionnaire)

    IKDC is a subjective patient reported outcome measure for knee specific disease. Scoring in range 0-100, which 0 is lowest score, and 100 is a highest score

    IKDC questionnaire was measured at pre operation (0 month), 3rd month, 6th month, 12th month, 24th month

Secondary Outcomes (4)

  • Change of Lachman Test

    at pre operation (0 month), 12th month, 24th month

  • Change of Pivot shift test

    at pre operation (0 month),12th month, 24th month

  • Change of Questionnaire of EQ5D

    at pre operation (0 month),12th month, 24th month

  • Total cost of treatment

    at 12th and 24 months

Study Arms (2)

ACL Reconstruction Group

This group received reconstruction treatment in Cipto Mangunkusumo Hospital, Gatot Subroto Hospital, Hasan Sadikin Hospital

Procedure: ACL Reconstruction surgery and Rehabilitation Treatment

Rehabilitation Group

This group received rehabilitation treatment with optional delayed reconstruction if needed in Arifin Achmad Hospital, Pekanbaru

Procedure: ACL Reconstruction surgery and Rehabilitation Treatment

Interventions

ACL Reconstruction surgery is a procedure to treat ACL injury by replacing the torn ligament with another. ACL Rehabilitation treatment is a procedure to treat ACL injury by muscle strengthening and exercise

ACL Reconstruction GroupRehabilitation Group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Young active population

You may qualify if:

  • Age between 18 to 40 years
  • Either sex
  • Isolated ACL tear not more than six weeks old to a previously uninjured knee or less than six months with showing acute symptoms (inflammation, swelling, knee effusion)
  • Tegner Activitiy Level of 5-9.

You may not qualify if:

  • Professional athletes or military
  • Collateral ligament rupture
  • Full-thickness cartilage lesion visualized
  • TAL below 5
  • Meniscal tear grade III on MRI.
  • Pregnancy
  • A history of deep vein thrombosis (DVT) or a disorder of the coagulative system
  • Claustrophobia
  • General systemic disease affecting physical function, any other condition or treatment interfering with the completion of the trial, including patients with metal devices or motion disorders
  • Hyperlaxity with a Beighton score of more than 4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arifin Achmad Hospital

Pekanbaru, Riau, 28133, Indonesia

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr

Study Record Dates

First Submitted

January 26, 2021

First Posted

February 10, 2021

Study Start

March 1, 2021

Primary Completion

June 30, 2024

Study Completion

December 31, 2024

Last Updated

May 28, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations